A Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetics of Deuremidevir Hydrobromide for Suspension

NCT05932459 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Deuremidevir Hydrobromide for Suspension 100mg
DRUG: Deuremidevir Hydrobromide for Suspension 300mg
DRUG: Deuremidevir Hydrobromide for Suspension 25mg
DRUG: Deuremidevir Hydrobromide tablets 100mg

Sponsor

Vigonvita Life Sciences